| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner, May Be Part of A 13(d) Group | 10% Owner, May Be A Part of A 13(d) Group
1 company
Aldagen Holdings, LLC last filed a Form 4 in May 2015, as 10% Owner, May Be Part of A 13(d) Group at AURX.
At the last filing, the largest reported position was 13,139,215 shares of AURX. The AURX filings lean toward selling, a net 440,350 shares.
Aldagen Holdings, LLC has 4 Form 4 filings on record from January 2015 to May 2015, all as 10% Owner, May Be Part of A 13(d) Group at Nuo Therapeutics (AURX), 2015.
The 7 reported transactions were 7 open-market sales.
Counted by filing, the open-market trades come to no purchases and 4 sales worth about $150K.
The largest open-market sale was 217,383 shares of AURX at an average $0.35 on January 12, 2015, about $76K.
Shares as reported in the last Form 4 for each company; the most recent is from May 2015. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 11, 2015 | AURX Nuo Therapeutics, Inc. | 10% Owner, May Be Part of A 13(d) Group | Sell | 50,000 | $0.27 | $13,500.00 | -0.4% | |
| Jan 20, 2015 | AURX Nuo Therapeutics, Inc. | 10% Owner, May Be Part of A 13(d) Group | Sell | 5,500 | $0.35 | $1,925.00 | - | |
| Jan 14, 2015 | AURX Nuo Therapeutics, Inc. | 10% Owner, May Be Part of A 13(d) Group | Sell | 167,467 | $0.35 | $58,613.45 | -1.4% | |
| Jan 12, 2015 | AURX Nuo Therapeutics, Inc. | 10% Owner, May Be A Part of A 13(d) Group | Sell | 217,383 | $0.35 | $76,084.05 | -1.7% |